TherapeuticsMD (TXMD) Assets (2010 - 2026)

TherapeuticsMD (TXMD) has reported Assets for 17 consecutive years, with $37.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets fell 2.53% year-over-year to $37.5 million; the trailing twelve-month figure through Jun 2026 stood at $37.5 million (down 2.53% YoY), and the FY2025 full-year result was $37.7 million, down 3.0% from the prior year.
• Assets was little changed at $37.5 million in Q2 2026 per TXMD's latest filing, from $37.6 million in the prior quarter.
• Across five years, Assets topped out at $146.2 million in Q2 2022 and bottomed at $37.5 million in Q2 2026.
• Historically, Assets has averaged $61.1 million across 5 years, with a median of $41.1 million in 2024.
• The sharpest annual moves came in 2023 and 2026: Assets tumbled 63.28% in 2023, then retreated 1.71% in 2026.
• Over 5 years, Assets stood at $90.5 million in 2022, then sank by 52.12% to $43.3 million in 2023, then slipped by 10.36% to $38.8 million in 2024, then fell by 3.0% to $37.7 million in 2025, then declined by 0.34% to $37.5 million in 2026.
• According to Business Quant data, Assets over the past three periods registered $37.5 million, $37.6 million, and $37.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.